217 related articles for article (PubMed ID: 18603474)
1. Fitness costs of resistance to antimalarial drugs.
Felger I; Beck HP
Trends Parasitol; 2008 Aug; 24(8):331-3. PubMed ID: 18603474
[TBL] [Abstract][Full Text] [Related]
2. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
Babiker HA; Hastings IM; Swedberg G
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
[TBL] [Abstract][Full Text] [Related]
3. Intensity of malaria transmission and the evolution of drug resistance.
Hastings IM; Watkins WM
Acta Trop; 2005 Jun; 94(3):218-29. PubMed ID: 15847846
[TBL] [Abstract][Full Text] [Related]
4. Should chloroquine be laid to rest?
Ginsburg H
Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
[TBL] [Abstract][Full Text] [Related]
5. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.
Hastings IM; Donnelly MJ
Drug Resist Updat; 2005; 8(1-2):43-50. PubMed ID: 15939341
[TBL] [Abstract][Full Text] [Related]
6. Malaria. Chloroquine makes a comeback.
Vogel G
Science; 2006 Nov; 314(5801):904. PubMed ID: 17095662
[No Abstract] [Full Text] [Related]
7. Resistance to antimalarial compounds: methods and applications.
Witkowski B; Berry A; Benoit-Vical F
Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance models for malaria.
Mackinnon MJ
Acta Trop; 2005 Jun; 94(3):207-17. PubMed ID: 15894181
[TBL] [Abstract][Full Text] [Related]
9. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
Schlitzer M
ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
[TBL] [Abstract][Full Text] [Related]
10. Seasonal fluctuation of drug-resistant malaria parasites: a sign of fitness cost.
Babiker HA
Trends Parasitol; 2009 Aug; 25(8):351-2. PubMed ID: 19632155
[No Abstract] [Full Text] [Related]
11. Drug resistance in malaria.
Parija SC; Praharaj I
Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
[TBL] [Abstract][Full Text] [Related]
12. [On inducible variations in genetics of malaria parasites from the view of emergence of chloroquine].
Yan JZ; Li M; Song GH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(6):363-5. PubMed ID: 12567617
[No Abstract] [Full Text] [Related]
13. The biology of malaria parasites. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1987; 743():1-229. PubMed ID: 3109131
[No Abstract] [Full Text] [Related]
14. [A new approach to overcoming the drug resistance of the causative agents of malaria].
Orlov VS; Rabinovich SA
Med Parazitol (Mosk); 1990; (5):18-21. PubMed ID: 2266896
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant malaria: molecular mechanisms and implications for public health.
Petersen I; Eastman R; Lanzer M
FEBS Lett; 2011 Jun; 585(11):1551-62. PubMed ID: 21530510
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in antimalarial drug development.
Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
[TBL] [Abstract][Full Text] [Related]
17. [Drug resistant malaria].
Kano S
Nihon Rinsho; 2003 Mar; 61 Suppl 3():214-20. PubMed ID: 12717974
[No Abstract] [Full Text] [Related]
18. Molecular monitoring of antimalarial drug resistance in India.
Ghosh SK
Indian J Med Microbiol; 2017; 35(2):155-156. PubMed ID: 28681800
[No Abstract] [Full Text] [Related]
19. [Drug resistance of Plasmodium and rational application of antimalarials].
Liu DQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Oct; 23(5 Suppl):355-61. PubMed ID: 16562468
[No Abstract] [Full Text] [Related]
20. Tolerance is the key to understanding antimalarial drug resistance.
Hastings IM; Watkins WM
Trends Parasitol; 2006 Feb; 22(2):71-7. PubMed ID: 16406706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
